https://seekingalpha.com/news/4150413-novo-nordisk-ozempic-targeted-medicare-pricing-talks?source=feed_sector_healthcare
Sep 17, 2024 - Novo Nordisk's (NVO) diabetes therapy Ozempic may be up for next Medicare drug pricing negotiations, a top company executive said. Read more here.
0
sa:1500083168182488400
0
https://seekingalpha.com/article/4721612-vnqi-international-reits-may-play-catch-up-to-us-peers?source=feed_tag_etf_portfolio_strategy
Sep 17, 2024 -
0
sa:4813928207864572770
0
https://seekingalpha.com/article/4721594-davidstea-inc-dteaf-q2-2024-earnings-call-transcript?source=feed_sector_transcripts
Sep 17, 2024 - DAVIDsTEA Inc. reported strong Q2 2024 earnings with sales up
0
sa:-8697208824244187348
0
https://www.rttnews.com/story.aspx?Id=3475617
Sep 17, 2024 - Hoth Therapeutics, Inc. (HOTH) Tuesday announced promising preclinical results for its investigational Alzheimer's drug, HT-ALZ. The company's shares were rising more than 15 percent in pre-market.
0
rttnews:-8939119214753354331
0
https://www.fool.com/investing/2024/09/17/billionaire-jeff-bezos-races-rocket-lab-and-a/?source=iedfolrf0000001
Sep 17, 2024 - SpaceX has a monopoly on reusable rockets right now, but within a year it could have competition.
0
fool:6563419246368910667
0
https://www.fool.com/investing/2024/09/17/cathie-wood-is-selling-the-trade-desk-should-you/?source=iedfolrf0000001
Sep 17, 2024 - Is the adtech stock's run-up over?
0
fool:-2303409944713784805
0
https://www.fool.com/investing/2024/09/16/dan-ives-predicts-an-apple-supercycle-with-the-new/?source=iedfolrf0000001
Sep 16, 2024 - In the pundit's view, the technology will inspire swarms of users to snap up the company's new smartphone line.
0
fool:-2008727864841054374
0
https://seekingalpha.com/news/4150038-cg-oncology-surges-7-seen-benefitting-from-johnson-johnson-bladder-cancer-asset-data?source=feed_sector_healthcare
Sep 16, 2024 - CG Oncology stock is up 7% following bladder cancer data released by Johnson & Johnson. Read more here.
0
sa:-8400303258331101871
0
https://seekingalpha.com/news/4150032-bristol-unveils-10-year-opdivo-yervoy-follow-up-data-melanoma?source=feed_sector_healthcare
Sep 16, 2024 - Bristol-Myers Squibb's Opdivo + Yervoy combo shows durable improvement in advanced melanoma over 10 years. Read more here.
0
sa:4524605117952810077
0
https://www.fool.com/investing/2024/09/16/how-much-will-pay-out-in-dividends-this-year/?source=iedfolrf0000001
Sep 16, 2024 - For income investors, this electric utility is worth getting amped up about.
0
fool:8639780044034794032
0